Swiss National Bank’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Swiss National Bank’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,100	Closed	-$692K	–	2536
2020 Q3	$692K	Hold	13,100	–	–	﹤0.01%	2271
2020 Q2	$803K	Buy	13,100 +2,600	+25%	+$150K	﹤0.01%	2223
2020 Q1	$594K	Hold	10,500	–	–	﹤0.01%	2104
2019 Q4	$598K	Buy	10,500 +300	+3%	+$15.9K	﹤0.01%	2368
2019 Q3	$546K	Hold	10,200	–	–	﹤0.01%	2336
2019 Q2	$609K	Buy	10,200 +500	+5%	+$31.5K	﹤0.01%	2352
2019 Q1	$605K	Hold	9,700	–	–	﹤0.01%	2304
2018 Q4	$588K	Buy	+9,700	New	+$580K	﹤0.01%	2288

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Swiss National Bank's BSTC Position: Q4 2020 in Review

Swiss National Bank sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 13,100 shares — an estimated $692K sold.

Swiss National Bank first reported a position in BSTC in Q4 2018 and held it in 8 quarters. The position peaked at $803K in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Swiss National Bank reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Swiss National Bank sold 13,100 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $692K.
Swiss National Bank first reported a position in BioSpecifics Technologies Corp. in Q4 2018 and held it in 8 quarters.
Swiss National Bank's BioSpecifics Technologies Corp. position peaked at $803K in Q2 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Swiss National Bank's 13F filing for Q4 2020, filed 5 Feb 2021.